Related Experiment Video
Updated: Feb 28, 2026
08:46
Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice
Published on: January 26, 2024
2.6K
Modeling the Phage Properties Best for Therapy
James J Bull1, Gurneet Kaur2, Stephen M Krone3
1Department of Biological Sciences, University of Idaho, Moscow, ID 83844, USA.
Viruses
|February 27, 2026
Summary
Phage therapy success can be predicted by phage properties like adsorption and growth rates, not just plaque formation. Computational models show these factors are crucial for effective bacterial infection treatment.
Area of Science:
- Bacteriology
- Virology
- Computational Biology
Background:
- Phage therapy uses bacteriophages to treat bacterial infections.
- Current selection criteria for therapeutic phages, like host range, do not guarantee treatment success.
- Improved predictors for phage efficacy are needed.
Purpose of the Study:
- To computationally investigate standard phage properties as predictors of phage therapy success.
- To identify which phage characteristics are most influential in suppressing bacterial infections.
Main Methods:
- Utilized computational models to simulate phage-bacterial interactions.
- Analyzed 2400 combinations of phage phenotypes (burst size, lysis rate, adsorption rate constant, intrinsic decay rate, growth rate).
- Defined treatment success as the number of phages required to achieve a 100-fold bacterial density reduction.
Main Results:
- Adsorption rate constant and growth rate were the most significant predictors of treatment success.
- Bacterial density was highly informative for predicting phage requirements.
- Burst size and lysis time showed minimal predictive value.
Conclusions:
- Adsorption rate constant and growth rate are key phage properties for successful phage therapy.
- Selection for broad host range may negatively impact phage adsorption and growth on specific hosts.
- Phage properties, particularly adsorption and growth rates, should be optimized for individual bacterial targets.
Related Concept Videos
01:30Lytic Cycle of Bacteriophages
78.6K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
78.6K
01:26DNA Bacteriophages
1.2K
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.2K
01:20Viral Replication: Lytic Cycle
2.0K
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
2.0K
01:29Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
00:43Lysogenic Cycle of Bacteriophages
68.3K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
68.3K
01:16Viral Replication: Lysogenic Cycle
2.0K
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
2.0K